ELEV — Elevation Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Elevation Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	79.4	146	90.3	83.1	93.2
Prepaid Expenses
Total Current Assets	80.8	149	93	88	94.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.056	0.038	0.098	0.059	0.034
Other Long Term Assets
Total Assets	80.9	149	94.2	89.1	95.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	6.79	8.79	15.7	4.14	4.47
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.8	8.8	45.1	34.3	35.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	74.1	141	49	54.8	60
Total Liabilities & Shareholders' Equity	80.9	149	94.2	89.1	95.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding